Leukine

Partner Therapeutics, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 31, 2023
Approval ID: bb9a3820-f31a-4dd9-bef4-97094c01a398
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LEUKINE safely and effectively. See full prescribing information for LEUKINE. LEUKINE (sargramostim) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 1991

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.